Subscribe to Biotech Blueprint, FREE weekly newsletter HERE.
This week, Biotech Blueprint breaks down the crosswinds shaping the industry:
– Novo Nordisk doubles down on AI drug discovery with an $812M Deep Apple partnership
– The FDA approves UroGen’s bladder cancer drug Zusduri, the first non-surgical option for NMIBC
– Gilead’s HIV program hits a clinical hold, but shares rebound as lenacapavir’s PDUFA nears
– RFK Jr. removes the entire CDC vaccine panel, replacing members with mRNA skeptics
– Senators Sanders and King reignite the push to ban direct-to-consumer drug ads
– CRISPR Therapeutics rides the FDA’s accelerated approval momentum
– Vaxart surges on promising data for its oral norovirus vaccine
Subscribe to stay ahead of the science, policy, and market signals shaping biotech.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.